Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine the safety and efficacy, measured as best objective response rate (BORR), of MDX-010 when administered in combination with a gp100 melanoma peptide vaccine and to demonstrate the independent contributions of the vaccine and MDX-010 when given to patients with unresectable Stage III or IV melanoma who have been previously treated with other agents.
Inclusion criteria
- HLA-A*0201-Positive Patients with Previously Treated, Unresectable Stage III or IV Melanoma